Sample | Title | Value | Rank |
GSM52504 | SK-MEL-2 cells treated with Ad-E2F-1 at MOI 2(sample 1) | 2295.5 | 98 |
GSM52508 | SK-MEL-2 cells treated with Ad-E2F-1 at MOI 2(sample 2) | 2152.3 | 98 |
GSM52518 | SK-MEL-2 cells treated with Ad-LacZ at MOI 2 plus doxorubicin (sample 1) | 2042.9 | 98 |
GSM52519 | SK-MEL-2 cells treated with Ad-LacZ at MOI 2 plus doxorubicin (sample 2) | 2362.1 | 98 |
GSM52516 | SK-MEL-2 cells treated with Ad-E2F-1 at MOI 2 plus doxorubicin (sample 1) | 2048.7 | 98 |
GSM52517 | SK-MEL-2 cells treated with Ad-E2F-1 at MOI 2 plus doxorubicin (sample 2) | 2372.5 | 98 |